Aprio Wealth Management LLC Cuts Position in Danaher Co. (NYSE:DHR)

Aprio Wealth Management LLC lowered its position in shares of Danaher Co. (NYSE:DHR) by 22.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,393 shares of the conglomerate’s stock after selling 394 shares during the period. Aprio Wealth Management LLC’s holdings in Danaher were worth $320,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Teachers Insurance & Annuity Association of America bought a new stake in Danaher in the third quarter valued at approximately $39,000. MidAtlantic Capital Management Inc. bought a new stake in Danaher during the 3rd quarter valued at $40,000. FSA Wealth Management LLC purchased a new stake in Danaher during the 3rd quarter valued at $50,000. Darwin Wealth Management LLC bought a new stake in Danaher in the 3rd quarter worth $55,000. Finally, Dunhill Financial LLC raised its stake in shares of Danaher by 45.1% during the third quarter. Dunhill Financial LLC now owns 222 shares of the conglomerate’s stock valued at $62,000 after acquiring an additional 69 shares during the last quarter. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on DHR shares. KeyCorp boosted their target price on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. TD Cowen raised their target price on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. Royal Bank of Canada decreased their price target on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Evercore ISI lifted their price objective on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research report on Tuesday, October 1st. Finally, Raymond James lowered their target price on Danaher from $310.00 to $300.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $286.80.

Danaher Stock Performance

Shares of NYSE:DHR opened at $239.83 on Tuesday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. The firm has a market cap of $173.22 billion, a PE ratio of 45.77, a price-to-earnings-growth ratio of 4.32 and a beta of 0.83. The firm’s 50 day simple moving average is $235.52 and its 200-day simple moving average is $253.65. Danaher Co. has a one year low of $222.53 and a one year high of $281.70.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analysts’ expectations of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. During the same period in the prior year, the business earned $2.02 EPS. As a group, equities analysts predict that Danaher Co. will post 7.5 EPS for the current year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. Danaher’s dividend payout ratio is presently 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.